C
ClearScanAI provides an AI-powered risk assessment tool, AISmartDensity®, that analyzes mammograms to identify patients at higher risk of missed breast cancer. This deep learning technology evaluates cancer likelihood, long-term risk, and tissue masking potential to guide supplemental screening decisions. The platform aims to enhance breast cancer detection programs by accurately targeting individuals who would benefit most from additional imaging like MRI.
Updated 3 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Product
Features
- ClearScanAI provides an AI-powered risk assessment tool, AISmartDensity®, that analyzes mammograms to identify patients at higher risk of missed breast cancer. This deep learning technology evaluates cancer likelihood, long-term risk, and tissue masking potential to guide supplemental screening decisions. The platform aims to enhance breast cancer detection programs by accurately targeting individuals who would benefit most from additional imaging like MRI.